Evidence map›Paper›PMID 39755990›Full record

ArticleClinical and experimental medicine2025

Changes in CD4

Paola Zuluaga, Coral Zurera-Egea, Daniel Fuster, Anna Hernandez-Rubio, Aina Teniente-Serra, Eva Martínez-Cáceres, Roberto Muga

Abstract read
In one paragraph

Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paola ZuluagaUniversitat Autònoma de Barcelona, Bellaterra, Spain. Paola.Zuluaga@uab.cat.ORCID https://orcid.org/0000-0002-0247-0351
Coral Zurera-EgeaDepartment of Cell Biology, Physiology and Immunology, Universitat Autónoma de Barcelona, Bellaterra, Spain.
Daniel FusterUniversitat Autònoma de Barcelona, Bellaterra, Spain.
Anna Hernandez-RubioDepartment of Internal Medicine, Hospital Universitari Germans Trias I Pujol, Ctra. Canyet, Badalona, Spain.
Aina Teniente-SerraDepartment of Immunology, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
Eva Martínez-CáceresDepartment of Immunology, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
Roberto MugaUniversitat Autònoma de Barcelona, Bellaterra, Spain.

Funding

Centres de Recerca de Catalunya 2021-SGR-00945Instituto de Salud Carlos III JR20/00016Instituto de Salud Carlos III RD21/0009/0004
6 · The paper itself

Abstract

Alcohol-related cirrhosis (AC) is a condition that impacts in immunity. We analyzed changes over time in CD4

Indexed as

CD4-Positive T-LymphocytesLiver Cirrhosis, AlcoholicT-Lymphocyte SubsetsAdultAgedFemaleHumansMaleMiddle AgedTh17 CellsTh1 CellsAdaptive immunityAlcohol-related cirrhosisAlcohol use disorderT cell differentiationT cell subsets

Identifiers

PMID39755990
PMCPMC11700915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.